The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours
- PMID: 26935559
- DOI: 10.1016/j.eururo.2016.02.029
The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours
Abstract
The fourth edition of the World Health Organization (WHO) classification of urogenital tumours (WHO "blue book"), published in 2016, contains significant revisions. These revisions were performed after consideration by a large international group of pathologists with special expertise in this area. A subgroup of these persons met at the WHO Consensus Conference in Zurich, Switzerland, in 2015 to finalize the revisions. This review summarizes the most significant differences between the newly published classification and the prior version for renal, penile, and testicular tumours. Newly recognized epithelial renal tumours are hereditary leiomyomatosis and renal cell carcinoma (RCC) syndrome-associated RCC, succinate dehydrogenase-deficient RCC, tubulocystic RCC, acquired cystic disease-associated RCC, and clear cell papillary RCC. The WHO/International Society of Urological Pathology renal tumour grading system was recommended, and the definition of renal papillary adenoma was modified. The new WHO classification of penile squamous cell carcinomas is based on the presence of human papillomavirus and defines histologic subtypes accordingly. Germ cell neoplasia in situ (GCNIS) of the testis is the WHO-recommended term for precursor lesions of invasive germ cell tumours, and testicular germ cell tumours are now separated into two fundamentally different groups: those derived from GCNIS and those unrelated to GCNIS. Spermatocytic seminoma has been designated as a spermatocytic tumour and placed within the group of non-GCNIS-related tumours in the 2016 WHO classification.
Patient summary: The 2016 World Health Organization (WHO) classification contains new renal tumour entities. The classification of penile squamous cell carcinomas is based on the presence of human papillomavirus. Germ cell neoplasia in situ of the testis is the WHO-recommended term for precursor lesions of invasive germ cell tumours.
Keywords: Male genital organs; Urogenital tract; WHO classification.
Copyright © 2016 European Association of Urology. Published by Elsevier B.V. All rights reserved.
Comment in
-
Pathology and Genetics: Tumours of the Urinary System and Male Genital System: Clinical Implications of the 4th Edition of the WHO Classification and Beyond.Eur Urol. 2016 Jul;70(1):120-123. doi: 10.1016/j.eururo.2016.03.011. Epub 2016 Mar 17. Eur Urol. 2016. PMID: 26996660 No abstract available.
Similar articles
-
The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours.Eur Urol. 2022 Nov;82(5):458-468. doi: 10.1016/j.eururo.2022.06.016. Epub 2022 Jul 16. Eur Urol. 2022. PMID: 35853783 Review.
-
The World Health Organization 2016 classification of testicular germ cell tumours: a review and update from the International Society of Urological Pathology Testis Consultation Panel.Histopathology. 2017 Feb;70(3):335-346. doi: 10.1111/his.13102. Epub 2016 Dec 14. Histopathology. 2017. PMID: 27747907 Review.
-
The World Health Organisation 2016 classification of penile carcinomas: a review and update from the International Society of Urological Pathology expert-driven recommendations.Histopathology. 2018 May;72(6):893-904. doi: 10.1111/his.13429. Epub 2018 Feb 9. Histopathology. 2018. PMID: 29105175 Review.
-
[International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia 2012].Cesk Patol. 2014;50(4):137-41. Cesk Patol. 2014. PMID: 25418900 Czech.
-
[Vancouver classification of renal tumors: Recommendations of the 2012 consensus conference of the International Society of Urological Pathology (ISUP)].Pathologe. 2015 May;36(3):310-6. doi: 10.1007/s00292-014-2030-z. Pathologe. 2015. PMID: 25398389 German.
Cited by
-
PTPRZ1 dephosphorylates and stabilizes RNF26 to reduce the efficacy of TKIs and PD-1 blockade in ccRCC.Oncogene. 2024 Dec;43(50):3633-3644. doi: 10.1038/s41388-024-03198-8. Epub 2024 Oct 23. Oncogene. 2024. PMID: 39443724
-
Anaplastic lymphoma kinase rearrangement-associated renal cell carcinoma: Rare subset case report.Urol Case Rep. 2024 Jul 10;55:102798. doi: 10.1016/j.eucr.2024.102798. eCollection 2024 Jul. Urol Case Rep. 2024. PMID: 39104401 Free PMC article.
-
Is percutaneous image-guided renal tumour ablation ready for prime time?Br J Radiol. 2020 Oct 1;93(1114):20200284. doi: 10.1259/bjr.20200284. Epub 2020 Jun 22. Br J Radiol. 2020. PMID: 32543890 Free PMC article. Review.
-
A Systematic Review of Immune Checkpoint Inhibitors in Non-Clear-Cell Renal Cancer.Kidney Cancer. 2022 Aug 4;6(2):115-127. doi: 10.3233/KCA-210012. eCollection 2022. Kidney Cancer. 2022. PMID: 36212797 Free PMC article.
-
m6A RNA Methylation Regulators Impact Prognosis and Tumor Microenvironment in Renal Papillary Cell Carcinoma.Front Oncol. 2021 Mar 16;11:598017. doi: 10.3389/fonc.2021.598017. eCollection 2021. Front Oncol. 2021. PMID: 33796449 Free PMC article.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous